Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer is a research paper published in Journal of Geriatric Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: R03AG064374
National Center for Advancing Translational Sciences
Grant: UL1TR002733
Ohio State University
Grant: 5 K12 CA133250-09
National Institutes of Health
Grant: P30CA016058
NCI NIH HHS
Grant: K12 CA133250
NIA NIH HHS
Grant: K76 AG074923
National Institutes of Health
Grant: 2K12CA133250-16
OSU K12 Training Grant in Oncology
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
National Institutes of Health
Grant: 5R03AG064374-02
Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Pilot Intervention Study
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
Center for Clinical and Translational Science, Ohio State University
Nationwide Children's Hospital
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals